Skip to main content
Michael McKenna, MD, Otolaryngology (ENT), Boston, MA

MichaelJ.McKennaMD

Otolaryngology (ENT) Boston, MA

Neurotology

Professor of Otolaryngology, Harvard Medical School

Dr. McKenna is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. McKenna's full profile

Already have an account?

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Otolaryngology - Head and Neck Surgery, 1984 - 1988
  • Huntington Memorial Hospital
    Huntington Memorial HospitalInternship, Transitional Year, 1982 - 1983
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1983 - Present
  • MA State Medical License
    MA State Medical License 1989 - 2025
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
  • American Board of Otolaryngology - Head and Neck Surgery Neurotology

Awards, Honors, & Recognition

  • Vegas Seven Castle Connolly, 2014
  • America's Top Doctors Castle Connolly, 2004-2014
  • Boston Magazine Castle Connolly, 2008-2013
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Akouos Discloses Lead Program, AK-OTOF, a Potential Gene Therapy for Sensorineural Hearing Loss
    Akouos Discloses Lead Program, AK-OTOF, a Potential Gene Therapy for Sensorineural Hearing LossSeptember 12th, 2019
  • Akouos Announces Executive Leadership Team Appointments
    Akouos Announces Executive Leadership Team AppointmentsSeptember 3rd, 2019
  • Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing
    Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve HearingAugust 7th, 2018

Professional Memberships